91av

Skip to content

2R2AKY2 Advertising for Wegovy (semaglutide) weight loss injections in the New York subway on Sunday, April 30, 2023. (? Richard B. Levine)

Health

2024 will see a new weight-loss drug that trumps Wegovy and Ozempic

Recently approved in the US, the weight-loss drug Zepbound will reach more people in 2024, with research suggesting its effects trump those of the much talked-about Wegovy and Ozempic

News

MRI scans of a healthy brain (left) and a brain with amyloid plaque deposits (right), a sign of Alzhiemer's disease

Health

2023 saw a cautious hope for Alzheimer's treatment but doubts remain

News

Julia author Sandra Newman:'Orwell's not the only literary misogynist'

Video

Julia author Sandra Newman:'Orwell's not the only literary misogynist'

Video

2R7B07K London, UK. 14th June 2023. UK screenwriters and Writers? Guild Of Great Britain (WGGB) members stage a rally in Leicester Square in solidarity with striking screenwriters in the USA. Credit: Vuk Valcic/Alamy Live News

Technology

Artificial intelligence and climate change were 2023's twin challenges

Leader

Health

Electronic pill monitors your breathing and heart rate from your gut

News

Technology

Flexible needle goes soft after injections for safety and comfort

News

Technology

Inflatable exoskeleton could build strength in injured wrists

News

Health

Covid-19 rebound affects 1 in 5 people after taking Paxlovid

News

Health

Weight-loss drug Wegovy can avert heart attacks - will this widen use?

Analysis

Health

Drug that cuts breast cancer risk set for wider use in UK

An oral medicine called anastrozole has been approved by the UK's drug regulatory agency for reducing the risk of breast cancer in post-menopausal women at moderate-to-high risk of the condition

News

Health

Why is there a shortage of ADHD drugs and what can people do?

News

Environment

The green transition will fail without more engineers

Comment

Environment

How countries can go fossil fuel free with wind and solar superpowers

Features

Health

US telehealth start-ups are booming – they may put patients at risk

Analysis